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ABSTRACT 
 
Introduction: Mahkota dewa (Phaleria macrocarpa) is an Indonesian fruit that contains 
antibacterial compounds, such as flavonoids, saponins, and tannins; it has been used as an 
alternative treatment for controlling infection. Objectives: This study aimed to examine the 
effect of mahkota dewa fruit extract on the formation of Porphyromonas gingivalis (P. 
gingivalis), Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), and 
Treponema denticola (T. denticola) biofilms in vitro. Methods: God’s crown fruit was 
extracted using the maceration technique, and then diluted into different concentrations (25%, 
12.5%, 6.25%, 3.125%, and 1.56%) using phosphate buffered saline (PBS). P. gingivalis 
ATCC-33277, A. actinomycetemcomitans ATCC-29522, or T. denticola ATCC-35405 were 
cultured in brain heart infusion (BHI) broth, 24h (anaerobic-condition), and then each type of 
bacteria (108CFU/mL) was distributed into a 96-well microplate to form a biofilm. 
Subsequently, the fruit extracts were distributed into the biofilm-containing well plates and 
incubated for 1h, 6h, and 24h. A biofilm without the fruit extract and chlorhexidine-gluconate 
(0.2%) was used as the negative and positive control, respectively. Crystal violet (0.5%w/v) was 
used to determine the density of the remaining biofilm using a microplate spectrophotometer 
(600 nm). Data were statistically analyzed using one-way ANOVA, and p <0.05 was set as the 
level of significance. Results: The mahkota dewa fruit extracts significantly inhibited the 
formation of a biofilm for all three bacterial strains at all concentrations and for each 
incubation time (p <0.05) based on optical density (OD)±SD.  The best concentration of fruit 
extract to inhibit biofilm formation was 25% for P. gingivalis (OD=0.19±0.06), 12.5% for A. 
actinomycetemcomitans (OD=0.14 ± 0.16), and 25% for T. denticola (OD=1.17±0.19) in 
comparison to the biofilm mass of the negative control, which was 1.67±0.06, 1.17±0.34, 
2.66±0.38 for P. gingivalis, A. actinomycetemcomitans, and T. denticola, respectively. 
Conclusion: Based on these results, mahkota dewa fruit extract can inhibit the formation of 
biofilm on P. gingivalis, A. actinomycetemcomitans, and T. denticola, and it may potentially be 
used to prevent the infection associated with periodontal disease. 
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INTRODUCTION 
 
Oral and dental disease, especially periodontal 
disease, is one of the main diseases around the world.1 
According to Basic Health Research (RISKESDAS), in 
2003, the percentage of people with oral and dental 
disease increased from 23.2% to 25.9%, and the 
prevalence of periodontal disease is 96.58%.2 Periodontal 
disease is defined as an inflammation in the gingival 
tissue, periodontal ligament, and bone structure which 
support teeth.3 The main etiology of periodontal disease 
is dental biofilm and bacterial plaque.4 Porphyromonas 
gingivalis (P. gingivalis), Treponema denticola (T. 
denticola), Tannerella forsynthensis, Aggregatibacter 
actinomycetemcomitans (A. actinomycetemcomitans), 
Fusobacterium nucleatum, Eikenella corrodens, and 
Prevotella intermedia are the types of bacteria involved 
in periodontal disease.5    
 
P. gingivalis and T. denticola are Gram-negative 
bacteria in the oral cavity that are involved in the 
pathogenesis of periodontal disease, especially chronic 
periodontitis. The bacteria destroy the periodontal 
ligament, leading to tooth loss. A. actinomycetem-
comitans is a Gram-negative anaerobic bacteria involved 
in the pathogenesis of aggressive periodontitis.6  
Accumulated bacteria build a biofilm in the oral cavity, 
leading to inflammation in the periodontal tissue.7 A 
biofilm is defined as a microorganism aggregation that 
adheres to the surface of teeth and is enclosed in 
extracellular polymeric substances (EPS).8 While biofilm 
is irremovable, the pathogenesis of dental biofilm plaque 
can be reduced in the oral cavity by balancing normal 
oral flora with oral hygiene procedures, such as tooth 
brushing, flossing, and rinsing with antimicrobial 
mouthwash.7    
 
Bacterial growth and the pathogenesis of periodontal 
disease can be overcome using various therapies, 
including non-surgical procedures, such as scaling and 
root planning, and surgical procedures alongside 
antibiotic therapy. Tetracycline, clindamycin, penicillin, 
metronidazole, macrolides, minocycline, chlorhexidine, 
and doxycycline are the most commonly used antibiotics, 
systemically or locally. Research has shown that the 
increasing prevalence of periodontal disease makes this 
disease difficult to overcome, even with the therapies 
mentioned above.5 The side effect of antibiotic therapy 
can cause pathogens to have antibiotic resistance.   
 
Since ancient times, people have been using natural 
products to treat various diseases due to their potentials 
of bioactivity, that can lead to drug discovery and 
development.9 The pharmaceutical industry has begun to 
take an interest in herbal plants that have antibacterial, 
antioxidant, and anti-inflammation properties.10 The 
increasing incidence of disease around the world, 
pathogenic bacterial resistance against antibiotics, and 
increasing healthcare costs in developing countries are 
factors that support the use of herbal plants.1 Therefore, a 
new exploration of herbal plants is needed.11 God’s 
Crown (mahkota dewa) is a native Indonesian plant that 
has the potential as an alternative to treat some dieases.12 
 
God’s Crown (Phaleria macrocarpa) originated 
from Papua in Indonesia, and it grows in the tropics.11  
Traditionally, this fruit has been found to have clinical 
advantages, and it is usually used to treat cancer, 
impotence, hemorrhoids, diabetes mellitus, allergies, 
hepar diseases, heart disease, kidney disease, blood 
disorders, stroke, itchiness, and some skin diseases.12 
Research has demonstrated that flavonoid, the largest 
component in God’s Crown extract, can inhibit Gram-
positive and Gram-negative bacteria.11,13 Secondary 
metabolite components of this plant, such as saponin, 
tannin, alkaloid, terpenoids, falerin, mangiferin, and 
gallic acid, have been tested in vitro; they have shown 
antitumor, anti-hyperglycemic, anti-hyperlipidemic, anti-
inflammation, anti-diarrheal, vasodilator, antioxidant, 
anti-viral, antibacterial, and anti-fungal properties, and, 
when taken as a dietary supplement, God’s Crown has 
been found to increase fertility in males.14-16  
 
In dentistry, many research have been conducted to 
find potential alternative treatments from natural products 
against oral diseases.  For example, it has been reported 
that bromelain, an enzyme isolated from Indonesia’s 
pineapple hump, was effective against the growth of 
endodontic pathogen E. faecalis in vitro.17 Other fruits, 
such as strawberry, in the form of crude extracts also 
have antibacterial activity against several oral pathogens 
in vitro, including E. faecalis and P. gingivalis.18 
Although God’s Crown has been known for its promising 
health benefits and widely  used in the field of alternative 
medicine to treat various diseases, it has not been 
optimally applied in dentistry.19  The present study aimed  
to determine if God’s Crown extract could reduce the 
bacterial density in periodontal disease caused by 
biofilms formed by P. gingivalis, A.  Actinomycetem-
comitans, and T. denticola, as well as multispecies 
biofilm, in vitro. 
 
MATERIALS AND METHODS 
 
This experimental laboratory in vitro research study 
aimed to investigate the inhibition property of God’s 
Crown extract (Phaleria macrocarpa) against the biofilm 
density of P.  gingivalis, A.  actinomycetemcomitans, and 
T.  denticola, using a biofilm assay method with a post-
test only control design. 
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God’s Crown Extraction 
 
The God’s Crown extract was obtained from the 
Perkebunan Borobudur & Extraction Center, Semarang, 
Indonesia. The extraction was performed by drying the 
God’s Crown fruit, scaled with a scale (Kern & Sohn, 
Balingen), and then sorted, cleaned, and smashed into 
small fragments.  The fragments were soaked in 70% 
ethanol and evaporated, then dried, to obtain the 
extracts.11,12 The dried extracts were diluted with 
aquadest to create four different concentrations. 
 
Phytochemical Screening 
 
The  God’s Crown extracts were tested for the 
presence of flavonoids, triterpenoids, alkaloids, saponins, 
tannins, phenolics, and glycosides. The  results are 
expressed  as  positive  (+)  for the  presence and negative 
(-) for the absence of phytochemicals substances. 
 
Bacterial Cultures 
 
P. gingivalis ATCC 33277, A. actinomycetem-
comitans ATCC 33384, and T. denticola ATCC 354045 
were cultured in brain heart infusion (BHI) broth (Merck 
Millipore, Darmstadt), and then incubated for 48h 
(JISICO incubator, Seoul) in an anaerobic environment. 
Turbidity was measured using a microplate reader 
(SAFAS Monaco, Monaco) with a wave length of 600 
nm; the sample was diluted by adding BHI broth until the 
bacterial concentration was 3x108 CFU/mL (OD600 = 
0,25).20    
 
Biofilm Assay 
 
For each of the three bacterial cultures, 200 ml of P. 
gingivalis ATCC 33277, A. actinomycetemcomitans 
ATCC 33384, and T. denticola ATCC 354045, was 
inserted into 96-well microplates (Nest Biotechnology, 
Jiangsu) using a micropipette (Corning, New York) 
coated with artificial saliva and incubated for 48h to form 
the biofilm.21,22 Then, different concentrations of God’s 
Grown extract (3.125%, 6.25%, 12.5%, and 25%) were 
added to the bacterial cultures, which were then 
incubated for 1h, 6h, and 24h.  Moreover, the microplate 
was rinsed twice with phosphate buffer saline (PBS) 
(Biomatik, Cambridge) and dried. Then, 200 mL of 
0.05% crystal violet solution was added to each well for 
15 min; rinsed with PBS.  In the final step, 200 mL of 
99% ethanol was added to the cultures, and the biofilm 
density was measured using a microplate reader with a 
wavelength of 600 nm. 
 
The data were analyzed using Shapiro-Wilk’s 
normality test. A comparative analysis was conducting 
using one-way ANOVA. The post-hoc test was used to 
measure the statistical significance. which was set at 
p<0.05. 
 
RESULTS 
 
The phytochemical test confirmed that this plant has 
some active components, such as alkaloids, saponins, 
tannins, phenolics, and flavonoids.  The results are shown 
in Table 1. The data showed that God’s Crown extract 
can reduce the biofilm density of P. gingivalis, A. 
actinomycetemcomitans, and T. denticola, as well as the 
density of the multispecies biofilm. It was found that the 
25% concentration of God’s Crown extract (incubated at 
24h) was the most effective for reducing the biofilm 
density of P.  gingivalis and T. denticola (Fig. 1 and 2). 
The 12.5% concentration of God’s Crown extract 
(incubated for 6h) was the most effective for reducing the 
biofilm density of A. actinomycetem-comitans  (Fig. 3). 
The concentration of God’s Crown extract that was most 
effective for reducing the density of the multispecies 
biofilm was 25%, incubated for 1h (Fig. 4).  
 
The statistical analysis data showed that the data was 
normally distributed (p>0.05).  Comparative analysis of 
the data with one-way ANOVA showed that there was 
significant difference in all concentrations compared to 
negative control (p<0.05). A post-hoc test was used to 
determine the statistically significant difference.  The 
results showed that there was a significant difference in 
the biofilm formation between all of the God’s Crown 
extract concentrations (3.125%, 6.25%, 12.5%, and 25%) 
at all three incubations times (1h, 6h, and 24h) and the 
negative control (the biofilm without the fruit extract). 
 
DISCUSSION 
 
God’s crown extract contains many bioactive 
compounds. Some of the compounds found in God’s 
Crown extract, such as flavonoids, saponins, and tannins, 
have been proven to have antibacterial activity.16 
Flavonoids (including kaempferol, myricetin, naringin, 
quercetin, and rutin) are the major bioactive components 
in God’s crown fruit extract.11 Medicinal plants that 
contain flavonoids often possess high antimicrobial 
activity against pathogens. For example, pomegranate 
juice has been reported to be effective in eradicating 
periodontal pathogens consisted of T. denticola, P. 
gingivalis, and A. actinomycetemcomitans in vitro 
because pomegranate contains flavonoids in abundance.23
  
The antimicrobial activity against pathogenic 
microorganisms happens through several mechanisms, 
including disruption of cytoplasmic membrane function, 
inhibition of nucleic acid synthesis, and alteration of 
energy metabolism.24 Flavonoids in God’s Crown extract 
can  reduce  the  formation  and  attachment  of   pseudo- 
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monas aeruginosa biofilm. Flavonoids can inhibit 
quorum sensing mechanism, a signal or communication 
system between bacterial cells in the biofilm that results 
in virulence. Some recent studies have shown that 
flavonoid can disrupt the interaction between acyl-
homoserine lactones (a Gram-negative bacteria signaling 
molecule), leading to the inhibition of quorum sensing.25 
Other components like tannins can resist some bacterial 
virulence by inhibiting biofilm formation and 
neutralizing the bacterial toxin.26  
 
Table 1. The phytochemical test results for God’s Crown 
extract  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The present study found that God’s Crown extract 
effectively reduces multispecies biofilm density. 
Takasaki et al. reported that P. gingivalis has a 
competitive relationship with A.  actinomycetemcomitans 
in biofilm.27 Among the bacteria in sub-gingival plaque 
in a biofilm community, there are cooperative and 
competitive relationships between species when forming 
the biofilm. The formation of biofilm is initiated by the 
attachment of initial colonizers (early colonizers) to the 
tooth surface or surrounding tissue, continued with the 
bonding of late colonizing bacteria. Takasaki et al. also 
reported that P. gingivalis (a late colonizer) can release 
A.  actinomycetemcomitans (an initial colonizer) that is 
already attached to the tooth surface, so there was less 
multispecies biofilm formation than mono-species 
biofilm formation.27 
 
Study  found that the flavonoids in God’s Crown 
extract can inhibit the growth of other Gram-negative 
bacteria, such as Escherichia coli (E. coli), and Gram-
positive bacteria, such as Staphylococcus aureus (S. 
aureus). The inhibition was more effective in S. aureus 
than in E. coli, because, as a type of Gram-negative 
bacteria, most of the cell membrane of E. coli consists of 
lipopolysaccharides and 2% – 10% consists of pepti-
doglycans; in Gram-positive bacteria, 50% of the cell 
membrane consists of peptidoglycans; the membrane 
does not contain any lipopolysaccharides.28  The 
flavonoids  in  God’s  Crown leaves or fruit make it more 
difficult for bacteria to penetrate lipopolysaccharides 
than peptidoglycans. Therefore, higher concentration of 
God’s Crown extract is needed.29 The present study’s 
findings agree with the results reported by Suryani et al.28 
which is that the flavonoids in God’s Crown extract can 
significantly reduce the density of the biofilm formed by 
P. gingivalis, A. actinomycetemcomitans, and T. 
denticola.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Reduction of P. gingivalis biofilm (OD) after 
probiotic treatment with God’s Crown extract in different 
concentrations (3.125%, 6.25%, 12.5%, 25%) after 1h, 
6h, and 24h of incubation period 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Reduction of T. denticola  biofilm (OD) after 
probiotic treatment with God’s Crown extract in different 
concentrations (3.125%, 6.25%, 12.5%, 25%) after 1h, 
6h, and 24h of incubation period 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Reduction of A. actinomycetemcomintans 
biofilm (OD) after probiotic treatment with God’s Crown 
extract in different concentrations (3.125%, 6.25%, 
12.5%, 25%) after 1h, 6h, and 24h of incubation period 
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Figure 4. Reduction of multispecies  biofilm (OD) after 
probiotic treatment with God’s Crown extract in different 
concentrations (3.125%, 6.25%, 12.5%, 25%) after 1h, 
6h, and 24h of incubation period 
 
CONCLUSION  
 
God’s Crown extract can reduce the density of the 
biofilm formed by P. gingivalis, A. actinomycetem-
comitans, T.  denticola, and multispecies biofilms.  The 
extract has the potential to become an alternative therapy 
for preventing periodontal disease. However, in vivo 
research is needed to perform a toxicity test to verify the 
safety of God’s Crown extract for use as a long-term 
medicine.  
 
CONFLICT OF INTEREST 
 
The authors declare that they have noconflict of 
interest. 
 
REFERENCES 
 
1. Palombo EA. Traditional medicinal plant extracts 
and natural products with activity against oral 
bacteria: Potential application in the prevention and 
treatment of oral diseases. eCAM. 2011;8(1):1–11. 
2. Situasi Kesehatan Gigi dan Mulut. Infodatin (Pusat 
Data dan Informasi Kementrian Kesehatan RI). 
2014. Hal 1. 
3. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. 
The prevalence and incidence of coronary heart 
disease is significantly increased in periodontitis: A 
meta-analysis. Am Hear J. 2007;154(5):830–7.  
4. Kim TS, Schenk A, Lungeanu D, Reitmeir P, 
Eickholz P. Nonsurgical and surgical periodontal 
therapy in single-rooted teeth. Clin Oral Investig. 
2007;11(4):391–9. 
5. Kothari S, Gnanaranjan G, Kothiyal P. Periodontal 
Chip: An Adjunct to Conventional Surgical 
Treatment. International Drug Research Technology. 
2012. 
6. Armitage GC. Comparison of the microbiological 
features of chronic and aggressive periodontitis. 
Periodontology 2000. 2010;53(1):70–88. 
7. Thomas JG, Nakaishi LA. Managing the complexity 
of a dynamic biofilm. Journal American Dental 
Association. 2006;137:10–15. 
8. Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial 
interactions in dental biofilm development. Journal 
Dental Research. 2011;88(11).  
9. Dias DA, Urban S, Roessner U. A historical 
overview of natural products in drug discovery. 
Metabolites. 2012;2:303-336. 
10. Manian R, Anusuya N, Siddhuraju P, Manian S. The 
antioxidant activity and free radical scavenging 
potential of two different solvent extracts of 
Camellia sinensis (L.) O. Kuntz, Ficus bengalensis 
L. and Ficus racemosa L. Food Chem. 
2008;107(3):1000–7. 
11. Hendra R, Ahmad S, Sukari A, Shukor MY, 
Oskoueian E. Flavonoid analyses and antimicrobial 
activity of various parts of Phaleria macrocarpa 
(Scheff.) Boerl fruit. Int J Mol Sci. 2011;12(6):3422–
31.  
12. Hendra R, Ahmad S, Oskoueian E, Sukari A, Shukor 
MY. Antioxidant, anti-inflammatory and cytotoxicity 
of Phaleria macrocarpa (Boerl.) Scheff fruit. BMC 
Complement Alternative Medicine [Internet]. 
2011;11(1):110. Tersedia pada: 
http://www.biomedcentral.com/1472-6882/11/110. 
13. Naharsari, Firman Wahyudi DA. Mahkota Dewa dan 
Manfaatnya. 2007. p. 8. 
14. Lay MM, Karsani SA, Mohajer S, Abd Malek SN. 
Phytochemical constituents, nutritional values, 
phenolics, flavonols, flavonoids, antioxidant and 
cytotoxicity studies on Phaleria macrocarpa 
(Scheff.) Boerl fruits. BMC Complement Altern 
Med. 2014;14(1):152. 
15. Altaf R, Asmawi MZ Bin, Dewa A, Sadikun A, 
Umar MI. Phytochemistry and medicinal properties 
of Phaleria macrocarpa (Scheff.) Boerl. extracts. 
Pharmacogn Rev. 2013;7(13):73–80. 
16. Shamsudin H, Yunus B, Uddin S. Bioactive 
compounds and advanced processing technology: 
Phaleria macrocarpa (sheff.) Boerl, a review. J 
Chem Technol Biotechnol. 2015;90(6):981–91. 
17. Liliany D, Widyarman AS, Erfan E, Sudiono J, 
Djamil MS. Enzymatic activity of bromelain isolated 
from pineapple (Ananas comosus) hump and its 
antibacterial effect on Enterococcus faecalis. Sci 
Dent J. 2018;2:39-50. 
18. Widyarman AS, Widjaja SB, Idrus E. Strawberry 
extract’s effects on Enterococcus faecalis and 
Porphyromonas gingivalis biofilms in vitro. Sci Dent 
J. 2017;1:1-5. 
19. Susilawati, Matsjeh S, Pranowo HD, Anwar C. Two 
isophalerin compounds from ethyl acetate of leave 
and fruit of mahkota dewa (Phaleria macrocarpa 
(Scheff.) Boerl.) and its antibacterial activity. 
Indones J Chem. 2015;15(2):179–86. 
61 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
Control
(-)
3.125% 6.25% 12.5% 25% Control
(+)
O
p
ti
ca
l 
D
en
si
ty
 (
O
D
) 
Extract Concentrations 
Multispecies Biofilm  
1 hr
6 hrs
24 hrs
Journal of Indonesian Dental Association 2019 2(2), 57-62 Radita DC, et al. 
20. Periasamy, Saravanan, KP. Aggregatibacter 
antinomycetemcomitans Builds Mutualistic Biofilm 
Communities with Fusobacterium nucleatum and 
Veillonella Species in Saliva. Infection Immunology. 
2009;77(9):3542–3551. 
21. Shao H, Lamont R DD. Autoinducer 2 is Required 
for Biofilm Growth of Aggregatibacter 
actinomycetemcomitans. Infection Immunology. 
2007;75(9):4211–4218 
22. Novak E, Shao H, Daep C DD. Autoinducer-2 and 
QseC Control Biofilm Formation and in vivo 
Virulence of Aggregatibacter 
actinomycetemcomitans. Infection Immunology. 
2010;78(7):2919–26. 
23. Widyarman AS, Suhalim OP, Nandary D, Theodorea 
CF. Pomegranate juice inhibits periodontal 
paathogens biofilm in vitro. Sci Dent J. 2018;3:101-
108. 
24. Xie Y, Yang W, Tang F, Chen X, Ren L. 
Antibacterial activities of flavonoids: structure-
activity relationship and mechanism. Curr Med 
Chem. 2015;22(1):132-49. 
25. Cushnie TPT, Lamb AJ. Recent advances in 
understanding the antibacterial properties of 
flavonoids. Int J Antimicrob Agents. 2011;38(2):99–
107. 
26. Daglia M. Polyphenols as antimicrobial agents. Curr 
Opin Biotechnol. 2012;23(2):174-81. 
27. Takasaki K, Fujise O, Miura M, Hamachi T, Maeda 
K. Porphyromonas gingivalis displays a competitive 
advantage over Aggregatibacter 
actinomycetemcomitans in co-cultured biofilm. J 
Periodontal Res. 2013;48(3):286–92. 
28. Suryani L, Stepriyani S. Daya Antibakteri Infusa 
Daun Mahkota Dewa ( Phaleria macrocarpa ) 
terhadap Staphylococcus aureus dan Eschericia coli 
The Antibacterial Activity of Mahkota Dewa leaf 
Infusion against Staphylococcus aureus and 
Eschericia coli. 2007;7(1):23–24. 
29. Mutschler. Dinamika Obat. Mathilda, Widiarto AS, 
editor. Bandung: ITB; 1991;664-667 
62 
Journal of Indonesian Dental Association 2019 2(2), 57-62 Radita DC, et al. 
